Carina Borst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carina Borst has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Dörte Symmank
Department of Dermatology, Medical University of Vienna, Vienna, Austria
3 shared publications Wolfgang Weninger
Department of Dermatology, Medical University of Vienna, Vienna, Austria
3 shared publications- Wolfgang Weninger
Department of Dermatology, Medical University of Vienna, Vienna, Austria
2 shared publications Adrian Tanew
University Department of Dermatology, Medical University of Vienna, Vienna, Austria
1 shared publication- Anke Strölin
Department of Dermatology Eberhard Karls University Tuebingen Germany
1 shared publication - Annette Høgh
Vascular Research Unit, Department of Vascular Surgery, Viborg Regional Hospital, Viborg, Denmark
1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by Springer Nature in BMC Infectious Diseases
Risk factors for onset, recurrence and prolonged hospitalization in patients with cellulitis: a retrospective case-control study
Background: Cellulitis is a common soft tissue infection; however, despite its prevalence, associated risk factors are not consistently defined in the literature. Methods: We conducted a retrospective case-control study of 1395 cellulitis patients and 667 controls, analyzing risk factors for disease development, recurrent episodes, and prolonged hospitalization using regression models. Results: Male gender (2.68; 2.11 to 3.40; p < 0.001), higher baseline age (1.03; 1.02 to 1.03; p < 0.001), tinea pedis (72.48; 20.89 to 251.45; p < 0.001), ulcers (45.79; 13.21 to 158.70; p < 0.001), traumatic wounds (229.26; 14.37 to 3656.53; p < 0.001), stasis dermatitis (10.81; 2.10 to 55.64; p = 0.004), eczema (13.14; 3.50 to 49.32; p < 0.001), venous insufficiency (2.36; 1.29 to 4.32; p = 0.005), lymphoedema (11.21; 3.66 to 34.28; p < 0.001), oedema not otherwise specified (13.12; 2.29 to 75.16; p = 0.004), diabetes mellitus (1.58; 1.09 to 2.30; p = 0.015), chronic kidney disease (2.29; 1.24 to 4.25; p = 0.008), and obesity (2.74; 1.81 to 4.17; p < 0.001) emerged as risk factors for disease onset. Obesity was also a consistent risk factor for multiple disease episodes (1.73; 1.02 to 2.96; p = 0.044) and prolonged hospitalization (1.72; 1.25 to 2.42; p = 0.002). Conclusions: Male gender, higher age, skin barrier breaches, oedema, diabetes mellitus, chronic kidney disease, and obesity might be strong risk factors for cellulitis with obesity predisposing also for multiple disease episodes and prolonged hospitalization.
- 29 September 2026
- Published by Springer Nature in BMC Infectious Diseases
Open AccessRisk factors for onset, recurrence and prolonged hospitalization in patients with cellulitis: a retrospective case-control study
Background: Cellulitis is a common soft tissue infection; however, despite its prevalence, associated risk factors are not consistently defined in the literature. Methods: We conducted a retrospective case-control study of 1395 cellulitis patients and 667 controls, analyzing risk factors for disease development, recurrent episodes, and prolonged hospitalization using regression models. Results: Male gender (2.68; 2.11 to 3.40; p < 0.001), higher baseline age (1.03; 1.02 to 1.03; p < 0.001), tinea pedis (72.48; 20.89 to 251.45; p < 0.001), ulcers (45.79; 13.21 to 158.70; p < 0.001), traumatic wounds (229.26; 14.37 to 3656.53; p < 0.001), stasis dermatitis (10.81; 2.10 to 55.64; p = 0.004), eczema (13.14; 3.50 to 49.32; p < 0.001), venous insufficiency (2.36; 1.29 to 4.32; p = 0.005), lymphoedema (11.21; 3.66 to 34.28; p < 0.001), oedema not otherwise specified (13.12; 2.29 to 75.16; p = 0.004), diabetes mellitus (1.58; 1.09 to 2.30; p = 0.015), chronic kidney disease (2.29; 1.24 to 4.25; p = 0.008), and obesity (2.74; 1.81 to 4.17; p < 0.001) emerged as risk factors for disease onset. Obesity was also a consistent risk factor for multiple disease episodes (1.73; 1.02 to 2.96; p = 0.044) and prolonged hospitalization (1.72; 1.25 to 2.42; p = 0.002). Conclusions: Male gender, higher age, skin barrier breaches, oedema, diabetes mellitus, chronic kidney disease, and obesity might be strong risk factors for cellulitis with obesity predisposing also for multiple disease episodes and prolonged hospitalization.
- Open Access
- 17 August 2026
- Published by Springer Nature in hautnah
- Vol. 25 (3) , 98-102
Klinik, Pathogenese und Therapie der Psoriasisarthrits – ein Update
Zusammenfassung: Die Psoriasisarthritis (PsA) ist eine chronisch-entzündliche Gelenkerkrankung, die oft mit einer Psoriasis (PsO) der Haut bzw. Nägel einhergeht. Die PsA ist durch (Ruhe‑)Schmerzen, Druckschmerzhaftigkeit und Schwellung der Gelenke gekennzeichnet und kann von den distalen Interphalangealgelenken der Hände und Füße bis zur Wirbelsäule potenziell alle Gelenke betreffen. Die PatientInnen mit PsA können zudem auch eine strahlenförmige Verdickung einzelner Finger oder Zehen (Daktylitis) und Schmerzen im Bereich von Sehneninsertionen im Sinne einer Enthesitis aufweisen. In der Labordiagnostik ist die Erkrankung unspezifisch, da sie üblicherweise seronegativ ist – sie geht also nicht mit charakteristischen Autoantikörpern einher. Eine Erhöhung des C‑reaktiven Proteins oder der Blutsenkungsgeschwindigkeit können hinweisend sein. Um bleibenden Gelenkschäden vorzubeugen, sind die Früherkennung und rechtzeitige Therapie essenziell.
- 17 August 2026
- Published by Springer Nature in hautnah
- Vol. 25 (3) , 98-102
Open AccessKlinik, Pathogenese und Therapie der Psoriasisarthrits – ein Update
Zusammenfassung: Die Psoriasisarthritis (PsA) ist eine chronisch-entzündliche Gelenkerkrankung, die oft mit einer Psoriasis (PsO) der Haut bzw. Nägel einhergeht. Die PsA ist durch (Ruhe‑)Schmerzen, Druckschmerzhaftigkeit und Schwellung der Gelenke gekennzeichnet und kann von den distalen Interphalangealgelenken der Hände und Füße bis zur Wirbelsäule potenziell alle Gelenke betreffen. Die PatientInnen mit PsA können zudem auch eine strahlenförmige Verdickung einzelner Finger oder Zehen (Daktylitis) und Schmerzen im Bereich von Sehneninsertionen im Sinne einer Enthesitis aufweisen. In der Labordiagnostik ist die Erkrankung unspezifisch, da sie üblicherweise seronegativ ist – sie geht also nicht mit charakteristischen Autoantikörpern einher. Eine Erhöhung des C‑reaktiven Proteins oder der Blutsenkungsgeschwindigkeit können hinweisend sein. Um bleibenden Gelenkschäden vorzubeugen, sind die Früherkennung und rechtzeitige Therapie essenziell.
- Open Access
- 20 March 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (4) , 845-847
Ixekizumab Type I Allergy in a Patient With Psoriasis
A 52‐year‐old Caucasian woman was referred for an allergy workup of suspected type I allergy to the interleukin (IL)‐17A inhibitor ixekizumab. Five months after ixekizumab initiation, she suddenly developed intense pruritus and three small wheals at the injection site approximately 30 min after injection, lasting up to 3 days. With each additional application, she experienced a crescendo‐like amplification of skin symptoms. Allergy skin tests with ixekizumab, adalimumab (anti‐TNF‐α), brodalumab (anti‐IL17RA), risankizumab (anti‐IL‐23p19) and tildrakizumab (anti‐IL‐23p19) were performed. Skin prick testing showed positive results for ixekizumab with negative results for all other tested biologics. Intradermal testing, confirmed positive reactivity for ixekizumab already at a lower concentration. Intradermal testing was also positive for undiluted brodalumab, risankizumab and tildrakizumab. Allergy skin tests confirmed type I allergy to ixekizumab and suggested cross‐sensitization to brodalumab, risankizumab and tildrakizumab, for which the patient was treatment‐naïve.
- 20 March 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (4) , 845-847
Open AccessIxekizumab Type I Allergy in a Patient With Psoriasis
A 52‐year‐old Caucasian woman was referred for an allergy workup of suspected type I allergy to the interleukin (IL)‐17A inhibitor ixekizumab. Five months after ixekizumab initiation, she suddenly developed intense pruritus and three small wheals at the injection site approximately 30 min after injection, lasting up to 3 days. With each additional application, she experienced a crescendo‐like amplification of skin symptoms. Allergy skin tests with ixekizumab, adalimumab (anti‐TNF‐α), brodalumab (anti‐IL17RA), risankizumab (anti‐IL‐23p19) and tildrakizumab (anti‐IL‐23p19) were performed. Skin prick testing showed positive results for ixekizumab with negative results for all other tested biologics. Intradermal testing, confirmed positive reactivity for ixekizumab already at a lower concentration. Intradermal testing was also positive for undiluted brodalumab, risankizumab and tildrakizumab. Allergy skin tests confirmed type I allergy to ixekizumab and suggested cross‐sensitization to brodalumab, risankizumab and tildrakizumab, for which the patient was treatment‐naïve.
- Open Access
- 1 July 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (3) , 631-644.e22
Development of a Cellular Assay as a Personalized Model for Testing Chronic Wound Therapeutics
- 1 July 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (3) , 631-644.e22
Open AccessDevelopment of a Cellular Assay as a Personalized Model for Testing Chronic Wound Therapeutics
- Open Access
- 1 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (11) , ofad519
Sexually Transmitted Dermatophytes Can Cause Severe Infection Among Men who Have Sex With Men as Tinea Genitalis
Very limited data on tinea genitalis, a potentially severe dermatophytosis transmitted during sexual intercourse affecting the genital area, suggest its potential to cause outbreaks. Thus, we investigated genital dermatophyte infections at an HIV/sexually transmitted infection clinic and identified 17 men who have sex with men (all people with HIV or pre-exposure prophylaxis users) diagnosed with tinea genitalis.
- 1 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (11) , ofad519
Open AccessSexually Transmitted Dermatophytes Can Cause Severe Infection Among Men who Have Sex With Men as Tinea Genitalis
Very limited data on tinea genitalis, a potentially severe dermatophytosis transmitted during sexual intercourse affecting the genital area, suggest its potential to cause outbreaks. Thus, we investigated genital dermatophyte infections at an HIV/sexually transmitted infection clinic and identified 17 men who have sex with men (all people with HIV or pre-exposure prophylaxis users) diagnosed with tinea genitalis.
- Open Access
- 15 December 2022
- Published by Elsevier in JID Innovations
- Vol. 3 (2) , 100176
Dermatologic Manifestations of Noninflammasome-Mediated Autoinflammatory Diseases
- 15 December 2022
- Published by Elsevier in JID Innovations
- Vol. 3 (2) , 100176
Open AccessDermatologic Manifestations of Noninflammasome-Mediated Autoinflammatory Diseases
- 20 June 2022
- Published by Springer Nature in ästhetische dermatologie & kosmetologie
- Vol. 14 (3) , 34-41
Pathogenese, Klinik und Therapie des Erysipels
- 20 June 2022
- Published by Springer Nature in ästhetische dermatologie & kosmetologie
- Vol. 14 (3) , 34-41
Pathogenese, Klinik und Therapie des Erysipels
- Open Access
- 4 March 2022
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 20 (4) , 525-527
Subcutaneous nodules on the upper extremity – an unusual presentation of Kimura’s disease
- 4 March 2022
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 20 (4) , 525-527
Open AccessSubcutaneous nodules on the upper extremity – an unusual presentation of Kimura’s disease
- Open Access
- 2 February 2022
- Published by Springer Nature in hautnah
- Vol. 21 (1) , 55-62
Pathogenese, Klinik und Therapie des Erysipels
Zusammenfassung: Das Erysipel ist eine häufig vorkommende, akut auftretende, bakterielle Infektion der Haut, welche oft mit Systemzeichen einhergeht. Ursächlich für diese häufige Dermatose sind zumeist β‑hämolysierende Streptokokken der Gruppe A (Streptococcus pyogenes). Typischerweise dringen Bakterien durch einen Substanzdefekt in die Haut ein und siedeln sich in den superfiziellen Lymphgefäßen der Dermis an. Das Erysipel tritt üblicherweise an der unteren Extremität auf, kann aber jedes Körperareal betreffen. Klinisch zeichnet es sich durch eine Rötung mit flammenartigen Ausläufern, einer Schwellung und Überwärmung des betroffenen Areals aus. Die Rötung kann aufgrund der Oberflächlichkeit des Entzündungsprozesses in der Regel gut von gesundem Gewebe abgegrenzt werden. Im Bereich des respektiven Lymphabstromgebiets kann es zu einer reaktiven Lymphadenopathie kommen. Darüber hinaus können sich die Patienten mit Fieber, Schüttelfrost und Tachykardie präsentieren. Laborchemisch zeichnet sich die Erkrankung durch eine Erhöhung der Leukozytenzahl mit Neutrophilie, des C‑reaktiven Proteins und der Blutsenkungsgeschwindigkeit aus. Therapeutisch kommt Penicillin zum Einsatz, wobei Clindamycin eine bewährte Therapiealternative darstellt. Das Erysipel heilt meist komplikationslos ab, allerdings können sich chronisch-rezidivierende Verläufe etablieren.
- 2 February 2022
- Published by Springer Nature in hautnah
- Vol. 21 (1) , 55-62
Open AccessPathogenese, Klinik und Therapie des Erysipels
Zusammenfassung: Das Erysipel ist eine häufig vorkommende, akut auftretende, bakterielle Infektion der Haut, welche oft mit Systemzeichen einhergeht. Ursächlich für diese häufige Dermatose sind zumeist β‑hämolysierende Streptokokken der Gruppe A (Streptococcus pyogenes). Typischerweise dringen Bakterien durch einen Substanzdefekt in die Haut ein und siedeln sich in den superfiziellen Lymphgefäßen der Dermis an. Das Erysipel tritt üblicherweise an der unteren Extremität auf, kann aber jedes Körperareal betreffen. Klinisch zeichnet es sich durch eine Rötung mit flammenartigen Ausläufern, einer Schwellung und Überwärmung des betroffenen Areals aus. Die Rötung kann aufgrund der Oberflächlichkeit des Entzündungsprozesses in der Regel gut von gesundem Gewebe abgegrenzt werden. Im Bereich des respektiven Lymphabstromgebiets kann es zu einer reaktiven Lymphadenopathie kommen. Darüber hinaus können sich die Patienten mit Fieber, Schüttelfrost und Tachykardie präsentieren. Laborchemisch zeichnet sich die Erkrankung durch eine Erhöhung der Leukozytenzahl mit Neutrophilie, des C‑reaktiven Proteins und der Blutsenkungsgeschwindigkeit aus. Therapeutisch kommt Penicillin zum Einsatz, wobei Clindamycin eine bewährte Therapiealternative darstellt. Das Erysipel heilt meist komplikationslos ab, allerdings können sich chronisch-rezidivierende Verläufe etablieren.
- 17 January 2022
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 81 (4) , 454-465
Cutaneous signs and mechanisms of inflammasomopathies
The emerging group of autoinflammatory diseases (AIDs) is caused by a dysregulation of the innate immune system while lacking the typical footprint of adaptive immunity. A prominent subgroup of AIDs are inflammasomopathies, which are characterised by periodic flares of cutaneous signs as well as systemic organ involvement and fever. The range of possible skin lesions is vast, ranging from urticarial, erysipelas-like and pustular rashes to erythematous patches, violaceous plaques and eventual necrosis and ulceration. This review provides a structured overview of the pathogenesis and the clinical picture with a focus on dermatological aspects of inflammasomopathies. Current treatment options for these conditions are also discussed.
- 17 January 2022
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 81 (4) , 454-465
Cutaneous signs and mechanisms of inflammasomopathies
The emerging group of autoinflammatory diseases (AIDs) is caused by a dysregulation of the innate immune system while lacking the typical footprint of adaptive immunity. A prominent subgroup of AIDs are inflammasomopathies, which are characterised by periodic flares of cutaneous signs as well as systemic organ involvement and fever. The range of possible skin lesions is vast, ranging from urticarial, erysipelas-like and pustular rashes to erythematous patches, violaceous plaques and eventual necrosis and ulceration. This review provides a structured overview of the pathogenesis and the clinical picture with a focus on dermatological aspects of inflammasomopathies. Current treatment options for these conditions are also discussed.